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Background: 37 million individuals are currently infected with Onchocerca volvulus (O. volvulus), a parasitic
nematode that elicits various dermal manifestations and eye damage in man. Disease control is primarily based on
distributing ivermectin in mass drug administration (MDA) programmes which aim at breaking transmission by
eliminating microfilariae (MF), the worm's offspring. The majority of infected individuals present generalized
onchocerciasis, which is characterized by hyporesponsive immune responses and high parasite burden including
MF. Recently, in areas that have been part of MDA programmes, individuals have been identified that present
nodules but are amicrofilaridermic (a-MF) and our previous study showed that this group has a distinct immune
profile. Expanding on those findings we determined the immune responses of O. volvulus-infected individuals to a
Plasmodium-derived antigen MSP-1 (merozoite surface protein-1), which is required by the parasite to enter
erythrocytes.
Methods: Isolated PBMCs from O. volvulus-infected individuals (164 MF+ and 46 a-MF) and non-infected volunteers
from the same region (NEN), were stimulated with MSP-1 and the resulting supernatant screened for the presence
of IL-5, IL-13, IFN-γ, TNF-α, IL-6, IL-17A and IL-10. These findings were then further analyzed following regression
analysis using the covariates MF, ivermectin (IVM) and region. The latter referred to the Central or Ashanti regions of
Ghana, which, at the time sampling, had received 8 or 1 round of MDA respectively.
Results: IL-5, IL-13 and IFN-γ responses to MSP-1 were not altered between NEN and O. volvulus-infected individuals
nor were any associations revealed in the regression analysis. IL-10, IL-6 and TNF-α MSP-1 responses were, however,
significantly elevated in cultures from infected individuals. Interestingly, when compared to a-MF individuals,
MSP-induced IL-17A responses were significantly higher in MF+ patients. Following multivariable regression analysis
these IL-10, IL-6, TNF-α and IL-17A responses were all dominantly associated with the regional covariate.
Conclusions: Consequently, areas with a lowered infection pressure due to IVM MDA appear to influence
bystander responses to Plasmodium-derived antigens in community members even if they have not regularly
participated in the therapy.
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Chronic filarial nematode infections in man are elicited
through Wuchereria bancrofti, Brugia species, Oncho-
cerca volvulus, Loa loa and Mansonella species which
reside in subcutaneous tissues and lymphatics [1,2]. O.
volvulus infections are primarily restricted to Africa and
are recognized as the agents responsible for river blind-
ness and various dermatological manifestations [3]. In-
fections are transmitted through the bite of Simulium
black flies that release L3 stage larvae into the host dur-
ing a blood meal. To complete the life-cycle, adult
worms produce microfilariae (MF) which reside in the
skin awaiting uptake by a further blood-feeding vector
[1]. The principal goal of current mass drug administra-
tion (MDA) programmes is to break transmission by
providing a yearly administration of ivermectin-based
drug regimes [4-6]. IVM treatment, however, has only
limited macrofilaricidal effects: successful elimination of
adult worms can only be achieved through the adminis-
tration of tetracycline antibiotics that target the essential
endosymbiont Wolbachia within the nematode [7-9].
Filariae are able to maintain a chronic status within
the host by influencing regulatory networks and main-
taining a strong presence of TGF-β and IgG4 [10-14]. In
endemic areas, the majority of O. volvulus-infected
individuals are classified as generalized onchocerciasis
(GEO), these patients present mild pathology, strong
regulatory responses including elevated IL-10-producing
Tr1 cells and IgG4 but high worm burden and MF loads
[12,14-17]. Even within the onchocercomas, the cellular
composition consists of Foxp3+ regulatory T cells and
TGF-β-positive cells [18,19]. GEO patients also present
hyporesponsive immune responses when whole blood or
isolated PBMCs are stimulated with various antigens -
including preparations of O. volvulus worm extracts
[15,20]. In contrast to infections with W. bancrofti, in
which only 50% of infected individuals are MF+ [21],
nearly all O. volvulus infections result in the release of
MF. The instance of amicrofilaridermic (a-MF) individ-
uals occurs when the worm is still in the prepatent state,
the female worms are no longer fecund after many years
or the individual has just received or has had repeated
rounds of IVM [20,22,23]. In a previous study we dem-
onstrated that MF+ and a-MF individuals had different
immune responses to filarial-specific or bystander anti-
gens. Moreover, using regression analysis we were able
to demonstrate that the responses were influenced by
both the individual ivermectin intake (IIT) and the
rounds of IVM MDA within the community [20].
Concomitant areas of different filarial and malaria in-
fections vary worldwide and there are currently no pre-
cise statistics on the frequencies of onchocerciasis and
malaria. Several studies have shown that deworming
elicits contrasting effects to bystander responses,including Plasmodium. Thus, within this study, we in-
vestigated how MF+ and a-MF O. volvulus-infected indi-
viduals responded to MSP-1 (merozoite surface protein-
1), which is required by Plasmodium to enter the
erythrocyte. Moreover, we determined whether these re-
sponses were affected by anthelmintic therapy since in-
dividuals stemmed from two distinct regions of Ghana
that had received differing numbers of IVM rounds. We
show that upon co-culture with MSP-1, IL-10, IL-6 and
TNF-α secretion by PBMCs from infected individuals
were significantly higher than from non-endemic nor-
mals (NEN) but this was not the case with regards to
IL-5 or IL-13 production. Moreover, MF+ individuals
produced significantly higher amounts of IL-17A than
the a-MF cohort. These findings were then analyzed
using a regression analysis employing the covariates MF,
IVM therapy and region. The regional covariate denotes
the Central and Ashanti regions of Ghana from which
individuals resided and at the time of sampling these re-
gions had received 8 and 1 rounds of therapy respect-
ively [24]. We found that the dominant variable in
MSP-1 induced responses was the region indicating that
bystander responses from O. volvulus-infected individ-
uals are influenced by the community intake of IVM.
Methods
Study population
210 male and female participants (18–55) were recruited
in 2009 as part of the study entitled "Comparison of
doxycycline alone vs doxycycline plus rifampicin in their
efficacy against onchocerciasis" registered with Current
Control Trials as ISRCTN68861628 (http://www.con-
trolled-trials.com/ISRCTN68861628/hoerauf ). Individ-
uals resided in 24 villages adjacent to the river Offin in
Ghana. These hyperendemic regions for onchocerciasis
but not other filarial infections (Ghana MoH-NTD 2007,
unpublished findings) were within vector range (<12 km)
and included the Upper and Lower Denkyira Districts in
the Central Region and the Amansie Central and Adanse
South Districts in the Ashanti Region. The data presented
here was collated prior to any treatment referred to in the
trial protocol. Ethical clearance, including immunological
studies, was granted by appropriate ethical committees at
the University of Bonn and the University of Science and
Technology in Kumasi. Samples from infection-free, non-
endemic normal (NEN), volunteers (23–59) were used for
comparison. Written informed consent was obtained from
all participants.
Ivermectin therapy and parasitology
Although the Ghanaian Ministry of Health has imple-
mented MDA in the Upper and Lower Denkyira districts
(>2001) and in the Amansie and Adanse South areas
(>2008) these regions have not been part of either OCP
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two regions had had 8 and 1 rounds of therapy respect-
ively, all individuals in our study had had, on average, an
individual IVM intake of 1.5. O. volvulus-infected indi-
viduals were recruited into the study on the presence of
at least one nodule but without severe skin lesions. NEN
were negative for MF, had no palpable onchocercomas,
and had no pathology related to onchocerciasis. All indi-
viduals were screened for the presence of dermal micro-
filariae (MF/mg skin) as previously described [8,20]. In
short, two skin biopsies (1–3 mg) from the buttocks
were removed with a corneoscleral (Holth) punch and
weighed using a electronic balance. During overnight
culture at room temperature in 0.9% NaCl solution, MF
emerged from the biopsies. Following microscopic
examination [8,20] MF load was calculated per mg skin.
All O. volvulus-infected and NEN individuals were
screened for other intestinal helminths (e.g. schisto-
somes, Ascaris). Infections were diagnosed using stand-
ard methods (Kato-Katz, and urine analysis) and 14/164
MF+ and 4/46 a-MF individuals were co-infected with
either hookworm (n = 13), Schistosoma mansoni (n = 2)
or S. haematobium (n = 4). Individuals were treated with
albendazole or praziquantel respectively. Details can be
viewed in Additional file 1: Table S1.
PBMC preparation, in vitro cell cultures and cytokine
measurements
PBMCs were isolated as previously described [20,25].
For culturing, 2 x 105 PBMCs/well were plated onto 96-
well plates (U-shaped, Greiner Bio-One, Frickenhausen,
Germany) in RPMI 1640 medium (PAA, Linz, Austria),
supplemented with 10% FCS, 2 mM L-glutamine, 50 μg/
ml penicillin/streptomycin and 50 μg/ml gentamicin (all
PAA). Cells were left un-stimulated or stimulated in
triplicate with 0.25 μg/ml of merozoite surface protein
(MSP-1) prepared as previously described [26] or anti-
CD3/anti-CD28 (10 μg/ml and 2.5 μg/ml) from eBioscience
(Frankfurt, Germany). Cultures were incubated for 72 hours
at 37°C in 5% CO2. Supernatants were then collected and
screened for IL-5, IL-13, IL-10, IL-17A, IFN-γ, TNF-α and
IL-6 cytokines using R&D Duo sets (R&D Systems,
Wiesbaden-Nordenstadt, Germany).
Statistical analysis
Statistical analyses were performed using the software
SPSS (IBM SPSS Statistics 20; Armonk, NY), the PRISM
5 programme (GraphPad Software, Inc., La Jolla, USA)
and SAS version 9.2 (SAS Institute Inc. Cary, NC, USA).
Since most of the variables did not show a normal distri-
bution, the following tests were chosen: to compare
three groups a Kruskal-Wallis-test was performed and, if
significant, followed by a Mann–Whitney–U test for a
further comparison of two groups. For comparisons ofcontinuous parameters the Spearman correlation was
used. Here, MSP-induced cytokine responses were cor-
related with the percentage of neutrophils and levels of
IL-5 and ECP (eosinophil cationic protein) in plasma in
each individual obtained from the study Arndts et al.,
[20]. Data was further assessed using a generalized linear
model. Initial analysis included parameters such as age,
nodule sites, co-infections and gender but no relevant
associations were detected.
Since the relevant correlations were factors associated
with IVM, MF and region we tightened the analysis and
evaluated: "times of individual IVM therapy (IIT)", "IVM
intake within the last 12 months", "MF-positivity", "mi-
crofilarial density" and the regional covariate "Central:
Ashanti". At the time of sampling, villages in the Central
region had had 8 years of MDA whereas those in the
Ashanti region had had only 1. Individuals from 14 vil-
lages (n = 82) comprised the "Central" region whereas
128 people came from 10 villages in the "Ashanti" region.
For this model continuous variables were rank-transformed.
If more than one covariate was below p < 0.1 following
univariable analysis, a further multivariable stage was con-
ducted (p < 0.05).
Results
Elevated IL-10 but not Th2 responses by O. volvulus-infected
individuals to MSP-1 antigen
Increased Th2 cytokine production is a hallmark of filar-
ial infections. To test whether these responses were also
modulated with regards to Plasmodium-derived antigen,
freshly isolated PBMCs from MF+, a-MF and NEN indi-
viduals were co-cultured with MSP-1 for 72 hours. Sub-
sequently, levels of IL-5 and IL-13 were measured in the
resulting culture supernatant. No significant differences
in these Th2 cytokine responses could be observed be-
tween the groups (Figures 1A and B). In contrast, IL-10
was significantly increased in both infected groups when
compared to NEN and levels were also principally higher
in the MF+ group when compared to a-MF individuals
(p = 0.08; Figure 1C). Our previous studies demonstrated
that IL-5 levels in plasma were significantly elevated in
this cohort of MF+ individuals [20]. Therefore, we corre-
lated these plasma IL-5 levels with the amount of MSP-
1-induced IL-10 and found a significant negative correl-
ation (Figure 1D).
Compared with NEN, PBMCs from MF+ individuals release
significantly more TNF-α and IL-6 to MSP-1-antigen
IL-6 and TNF-α belong to the innate cytokines, they
play important roles in the pathogenesis of malaria
[27,28]. Therefore, we investigated their induction after
PBMCs from O. volvulus-infected and NEN individuals
were stimulated with MSP-1. Additionally, PBMCs of all
three groups were stimulated with the classical T cell
Figure 1 MSP-1 stimulation alters IL-10 but not Th2 responses. Isolated PBMCs (2 x 105/well) from NEN (n = 12) or O. volvulus-infected MF+
(n = 164) or a-MF (n = 46) patients were stimulated with MSP-1 (0.25 μg/ml) for 72 hours. Thereafter, levels of IL-5 (A), IL-13 (B) and IL-10 (C) were
measured in the culture supernatants via ELISA. Data are plotted as fold increase over unstimulated controls. Graphs show box whiskers with
median, interquartile ranges and outliers. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and Mann–
Whitney tests. (D) MSP-1 induced IL-10 levels were correlated with the amount of IL-5 in plasma [20] and tested for statistical significance using
the spearman correlation test.
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both innate cytokines were significantly up-regulated
upon contact with MSP-1 or anti-CD3/anti-CD28 in in-
fected individuals when compared to NEN (Figures 2A
to D). In addition, MF+ patients produced significantly
more TNF-α than a-MF participants after anti-CD3/anti-
CD28 stimulation (Figures 2B). However, no significant dif-
ferences in either IL-6 or TNF-α production to MSP-1 were
observed between the infected groups (Figures 2C and D
respectively). Nevertheless, MSP-1-induced cytokine
levels were negatively correlated (IL-6; r = −0.178 and
TNF-α; r = −0.147) with the amount of IL-5 in plasma
(Figures 2E and F).
Up-regulated IL-17A responses to MSP-1 in MF+
individuals
Next, we evaluated the release of IFN-γ and IL-17A fol-
lowing MSP-1 stimulation. The production of IFN-γ wasnot significantly altered between the groups (Figure 3A).
In contrast, IL-17A was significantly up-regulated in the
MF+ group when compared to a-MF patients but not
the NEN cohort (Figure 3B). Previous immune profiling
of this cohort revealed that MF+ individuals had elevated
levels of ECP and reduced numbers of peripheral neu-
trophils [20]. Here we demonstrate that levels of plasma
derived ECP negatively correlated (r = −0.185) with the
amount of IFN-γ secreted by PBMCs following MSP-1
stimulation (Figure 3C). Furthermore, the percentage of
neutrophils was negatively correlated (r = −0.222) to MSP-
1 induced IL-17A release (Figure 3D).
Multivariable regression analysis reveals that immune
responses to MSP-1 is mainly associated with ivermectin
therapy at the community level
As already described [20,23] the occurrence of a-MF pa-
tients is considered to be the result of repeated IVM
Figure 2 Elevated innate cytokines in infected individuals. Isolated PBMCs (2 x 105/well) from NEN (n = 12) or O. volvulus-infected MF+
(n = 164) or a-MF (n = 46) patients were stimulated with either anti-CD3/anti-CD28 (10 and 2.5 μg/ml respectively, A and B) or with MSP-1
(0.25 μg/ml, (C and D) for 72 hours. Thereafter, levels of IL-6 (A and C) and TNF-α (B and D) were measured in the culture supernatants via ELISA.
Data are plotted as fold increase over unstimulated controls. Graphs show box whiskers with median, interquartile ranges and outliers. Statistical
significances between the indicated groups were obtained after Kruskal-Wallis and Mann–Whitney tests. MSP-1 induced IL-6 (E) and TNF-α
(F) levels were correlated with the amount of IL-5 in plasma [20] and tested for statistical significance using the spearman correlation test.
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to the Ashanti region, at the time of sampling, MDA
programmes had run 7 years longer in the Central re-
gion. To gain insight into whether the previous intake of
IVM on an individual level or the frequency of IVM dis-
tribution within the community was associated with
MSP-1 induced immunological responses, we performeda multivariable regression analysis which included the
variables “MF-positive”, “MF/mg”, “times of individual
IVM therapy (IIT)”, “IVM in the last 12 months” and
“Central: Ashanti” as already described in Arndts et al.,
[20]. The results of this MSP-1 based regression analysis
are shown in Table 1. Levels of IL-5, IL-13 and IFN-γ
that were released upon MSP-1 stimulation were not
Figure 3 Up-regulated IL-17A response in MF+ individuals. Isolated PBMCs (2 x 105/well) from NEN (n = 12) or O. volvulus-infected MF+
(n = 164) or a-MF (n = 46) patients were stimulated with MSP-1 (0.25 μg/ml) for 72 hours. Thereafter, levels of IFN-γ (A) and IL-17A (B) were
measured in the culture supernatants via ELISA. Data are plotted as fold increase over unstimulated controls. Graphs show box whiskers with median,
interquartile ranges and outliers. Statistical significances between the indicated groups were obtained after Kruskal-Wallis and Mann–Whitney tests.
(C) MSP-1 induced IFN-γ levels were correlated with the amount of ECP in plasma [20] and (D) MSP-1 induced IL-17 responses were correlated with
the percentage of neutrophils [20]. Both correlations were tested for statistical significance using spearman correlation test.
Table 1 Regression analysis between MF+ and a-MF patients
Parameter Stimulus Associations with univariable analysis Multivariable analysis
C:A MF/mg MF+ IIT IVM-12
IL-5 MSP-1 X X X X X —
IL-13 MSP-1 X X X X X —
IL-10 MSP-1 p = 0.0067 X p = 0.0803 X X C:A (C↓A↑, p = 0.0067)
IL-6 MSP-1 p = 0.0016 X X X X nd
αCD3/αCD28 p = 0.0014 X X X X nd
TNF-α MSP-1 p = 0.0050 X p = 0.0224 p = 0.0523 p = 0.0296 C:A (C↓A↑, p = 0.0037)
αCD3/αCD28 p = 0.0025 X X X X nd
IL-17A MSP-1 p = 0.0054 X p = 0.0271 p = 0.0428* p = 0.0377 C:A (C↓A↑, p = 0.0066)
IFN-γ MSP-1 X X X X X —
*denotes negative correlation. 'nd' denotes that only one covariate was below p < 0.1 and therefore no multivariable analysis was done.'—' denotes no
associated covariate.
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duced IL-10 production was associated with the regional
(C:A) and MF+ covariates with region being the most as-
sociated factor. This implies that IL-10 secretion of
PBMCs isolated from individuals in the Central region
was lower than those from patients in the Ashanti re-
gion. Although IL-17A and TNF-α responses to MSP-1
were associated with all covariates except MF/mg, again
the most associated covariate was C:A. In contrast,
TNF-α responses to anti-CD3/anti-CD28 were only as-
sociated with the region and this was also the case with
both IL-6 responses. As shown previously, the frequency
of IVM distribution within the community was associ-
ated with immune responses and expanding on those
findings we demonstrate here that this also influences
bystander responses to Plasmodium-derived antigens.
Discussion
According to epidemiological surveys, there are different
frequencies of filarial and malaria co-infections within
endemic regions. With regards to W. bancrofti, parts of
South America, Kenya and Tanzania are reported to
have co-infection rates of 3.3%, 4.3%, 11% respectively
[29-31]. Surveys of M. perstans-infected pregnant
women in areas of Uganda were reported to be 18% co-
infected with malaria [32]. Nevertheless, a matched pro-
spective study revealed that co-infection with filariae (W.
bancrofti and M. perstans) did not alter susceptibility or
severity of acute malaria infection [33]. Currently, a
comprehensive overview regarding areas with overlap-
ping O. volvulus and Plasmodium infections is missing.
One study has shown however that in a rural district of
Nigeria approximately 8.4% of the community is co-
infected [34]. In this study, we demonstrate that O. vol-
vulus-infected individuals, residing within co-endemic
areas of malaria in Ghana, presented increased IL-6,
TNF-α and IL-10 production in response to the P. fal-
ciparum-derived antigen MSP-1 when compared to un-
infected individuals. Th2 responses to MSP-1 on the
other hand were comparable in all groups. However,
when comparing infected groups, IL-17A responses to
MSP-1 were significantly higher in individuals that were
MF+. Such elevations were unique to MSP-1 since ex-
posure to filarial (O. volvulus or Brugia malayi) antigens
or other bystander antigens (PPD or LPS) were compar-
able between the groups [20]. Regression analysis further
revealed that these MSP-1 induced IL-17A responses
were associated with all covariates except microfilarial
load but were most strongly associated with the regional
covariate. Since this IL-17A response was lower in indi-
viduals from the Central region, who had had more
rounds of MDA, our data indicate that such lowered in-
fection pressure influences bystander responses to Plas-
modium-derived antigens. This further indicates thatimmune responses to Plasmodium antigens are modu-
lated even if community members did not regularly par-
ticipate in therapy.
Interestingly, studies have shown that functional T cell
(e.g. IL-17A) responses and the balance between effector
and regulatory T cell subsets in the skin relies on signals
from commensal microbiota [35] and furthermore
changes in gut microbiota have no effect on cutaneous
immune homeostasis [36]. Indeed, reconstitution of
germ-free mice with Staphylococcus epidermidis restored
protective immune responses during Leishmania major
infection. Moreover, this cutaneous commensal exerted
its effect through IL-1 signaling which is required for ef-
fector T cell function including IL-17A T cells [36]. This
raises the hypothesis therefore whether Wolbachia, re-
leased from dying MF, could modulate IL-17A responses
directly in the skin. In association, we recently observed
elevated Th17 but decreased Treg cells in individuals
with hyper-reactive forms of onchocerciasis, revealing a
further association between severe skin pathology and
IL-17 effector T cells [37]. With regards to lymphatic fil-
ariasis, re-stimulation of PBMCs with filarial antigen re-
vealed elevated expression of IL-17A and F in
individuals with severe forms of pathology [38]. When
comparing homeostatic levels of IL-17A-producing CD4
+ T cells, Metenou et al., observed elevated frequencies
in individuals infected with filariae (W. bancrofti and M.
perstans) compared to non-infected persons [10]. In an-
other study with the same groups, no differences in IL-
17A production could be observed after stimulation with
Mal-Ag (Plasmodium falciparum schizont extract), Bru-
gia-derived antigen or SEB (Staphylococcus aureus en-
terotoxin B) [39]. In association, we previously revealed
that PBMC cultures from asymptomatic MF+ and MF−
W. bancrofti-infected individuals produced very little, if
any, IL-17A to Brugia malayi-derived antigen or LPS.
Significantly elevated levels of IL-17A were released
however from cultures of MF− individuals upon activa-
tion with anti-CD3/anti-CD28. This was also observed
with MSP-1 albeit very few individuals responded [25].
Using flow cytometry it was further observed that the
net frequency of IL-17A-producing CD4+ T cells in
asymptomatic P. falciparum-infected individuals in-
creased upon stimulation with Mal-Ag but if individuals
were co-infected with filariae (W. bancrofti and M. per-
stans) levels did not change [40]. Although no studies
have compared Plasmodium vivax infections with filarial
co-infections it has been shown that the number of IL-
17 producing CD4+ T cells is significantly increased dur-
ing uncomplicated acute vivax malaria and directly cor-
related with elevated IFN-γ producing cells as well [41].
The presence of both IL-17 and IFN-γ in P. vivax indi-
viduals would create a pro-inflammatory environment
and consequently improve responses to the parasite.
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that IL-17A may have a protective role since such in-
fected IL-17 deficient mice had higher levels of parasit-
emia and shortened survival rates [42]. Thus, one could
speculate that increased levels of MSP-1 induced IL-17A
in MF+ O. volvulus-infected individuals could be benefi-
cial in terms of effective immune responses against mal-
aria re-infection. We further observed a negative
correlation between MSP-1 induced IL-17A responses
and the percentage of neutrophils in blood. The role of
neutrophils during malarial pathogenesis is still under
debate but some studies have shown that neutrophil in-
filtration, activation, and dysfunction may worsen the in-
fection outcome or instigate a predisposition to
secondary bacterial infections [43]. Indeed, Chen et al.
demonstrated a fundamental role for neutrophils during
the pathogenesis of murine ECM by modulating Th1
cytokine expression [44]. Extrapolating those findings to
our current study may indicate that such IL-17A re-
sponses by MF+ O. volvulus-infected individuals may be
protective against malaria infection.
Although most studies have concentrated on P. falcip-
arum infections, a study from Winkler and colleagues
observed immune differences between MF+ and MF− lo-
iasis patients with a small cohort of individuals co-
infected with P. malariae. They showed that in compari-
son to amicrofilaremic individuals, MF+ patients had
strong CD4+ Th2 cell responses although the frequency
of IL-5 secreting cells and CD8+ T cell populations
remained equal. The immune profiles of co-infected in-
dividuals were on a par with the MF− group [45]. With
regards to lymphatic filariasis, no differences in the fre-
quency of IL-5+or IL-4+ secreting CD4+ T cells were ob-
served between P. falciparum-infected and co-infected
individuals after Mal-Ag stimulation [40] but the authors
did observe decreased frequencies of IFN-γ producing
cells in the co-infected group [40]. In response to MSP-
1, our previous LF study showed no differences in either
IFN-γ, IL-5 nor IL-13 between MF+ and MF− groups.
PBMCs from MF+ individuals did however produce re-
duced amounts of MSP-specific TNF-α, IL-10 and IL-6
[25]. In association, decreased malaria-specific IFN-γ se-
cretion by individuals with patent infections was shown
to be IL-10 dependent [39]. Our data here provide evi-
dence that MSP-1-induced IL-10, IL-6 and TNF-α re-
sponses are negatively correlated with IL-5 levels in
plasma. The role of IL-5 in the context of malaria has so
far been studied to a very limited extent and needs fur-
ther investigation. Nevertheless, a study from Prakash
et al. has shown that high levels of plasma IL-5 were
found to be associated with a mild form of malaria [46].
In the present study, levels of MSP-1 induced IFN-γ
were also negatively correlated to plasma levels of ECP
and the latter one was described to be increased inpatients with cerebral compared to uncomplicated mal-
aria [47]. Adu et al. claimed in their study a so far
unrecognized role for eosinophils in cerebral malaria,
which also involves ECP. IL-5 is a potent activator of eo-
sinophils and together with elevated IgE levels is typic-
ally associated with cerebral malaria [48]. Currently, the
most effective factors in preventing malaria infection are
considered to be an early peak of IFN-γ and TNF-α but
these cytokines have also been associated with the devel-
opment of more serious pathology [49,50]. Our findings
here demonstrate that proficient IL-17A responses to
Plasmodium antigens in O. volvulus-infected patients
are dependent on the presence of MF. Moreover, since
an amicrofilaridermic state is a consequence of repeated
MDA therapy we further reveal that these IL-17A re-
sponses are reduced in communities that have had more
IVM therapy but in addition overspill onto individuals
that have not received IVM themselves.
Conclusions
We show here that IL-17A responses to a Plasmodium-
derived antigen were exclusively elevated in O. volvulus-
infected individuals that have not received many rounds
of MDA (8 rounds in the Central versus 1 round in the
Ashanti region). This indicates, therefore, that immune
responses to bystander antigens are not only modulated
by helminth co-infections per se but are also altered by
the amount of antihelmintic therapy taken on a com-
munity level. Much debate surrounds the issue as to
whether deworming in malaria endemic areas is benefi-
cial or not especially when vector biology strongly deter-
mines which parasite is the primary or secondary agent.
Such findings need to be addressed or taken into consid-
eration at the community level when commencing with
MDA programmes.
Additional file
Additional file 1: Table S1. All participants were screened for other
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had a dual infection.
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